𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Single-Dose Fosaprepitant for the Prevention of Chemotherapy-Induced Nausea and Vomiting Associated With Cisplatin Therapy: Randomized, Double-Blind Study Protocol--EASE

✍ Scribed by Grunberg, S.; Chua, D.; Maru, A.; Dinis, J.; DeVandry, S.; Boice, J. A.; Hardwick, J. S.; Beckford, E.; Taylor, A.; Carides, A.; Roila, F.; Herrstedt, J.


Book ID
125472996
Publisher
American Society of Clinical Oncology
Year
2011
Tongue
English
Weight
152 KB
Volume
29
Category
Article
ISSN
0732-183X

No coin nor oath required. For personal study only.


πŸ“œ SIMILAR VOLUMES


Randomized, placebo-controlled, pilot st
✍ Jon D. Herrington; Adam D. Jaskiewicz; Juhee Song πŸ“‚ Article πŸ“… 2008 πŸ› John Wiley and Sons 🌐 English βš– 151 KB

## Abstract ## BACKGROUND. The combination of palonosetron and aprepitant is safe and effective in the prevention of chemotherapy‐induced emesis (CIE). The purpose of this pilot study was to ascertain the effectiveness of 1‐day versus 3‐day aprepitant in the prevention of acute and delayed nausea